News - Edwards Air Force Base
WEBAug 29, 2011 · B-2 Returns to Edwards on 35th Anniversary of First Flight. Edwards Air Force Base revisited a significant chapter of aviation history with the return of the B-2 Spirit on July 17, 35 years since its first flight from Air Force Plant 42, in Palmdale, California to Edwards. Aug. 12, 2024.
Edwards Lifesciences to Sell Critical Care to BD
WEBJun 3, 2024 · IRVINE, CA-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in …
Edwards Lifesciences Expands Structural Heart Portfolio With ...
WEBJul 24, 2024 · IRVINE, Calif.-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.
Edwards Lifesciences Reports Second Quarter Results
WEBJul 24, 2024 · Adjusted research and development expenses in the second quarter were $303 million, or 18.6% of sales, compared to $270 million in the prior year. The increase was driven by continued investments in transcatheter valve innovations, including clinical trial …
Edwards Lifesciences gains amid takeover speculation
WEB6 days ago · Edwards Lifesciences (NYSE:EW) edged higher by 0.7% amid takeover speculation for the medical device maker. Edwards (EW) may have attracted takeover interest from an unnamed suitor, according...
Edwards Lifesciences Corporation (EW) Latest Stock News
WEBGet the latest Edwards Lifesciences Corporation (EW) stock news and headlines to help you in your trading and investing decisions.
Edwards Lifesciences Reports First Quarter Results
WEBApr 25, 2024 · IRVINE, Calif.-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook. Q1 sales grew 10% on a reported and constant currency 1 basis to $1.6 billion. Q1 TAVR sales grew 6%; constant currency sales grew 8% adjusted for billing days. Q1 TMTT sales grew 75%
BD to Acquire Edwards Lifesciences' Critical Care Product Group …
WEBJun 3, 2024 · BD today announced a definitive agreement to acquire Edwards Lifesciences' Critical Care product group, a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new...
Edwards’ EVOQUE Valve Replacement System First Transcatheter …
WEBIRVINE, Calif., February 02, 2024 -- (BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first...
Edwards Lifesciences Corp - Edwards’ EVOQUE Valve …
WEBFeb 2, 2024 · Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).